Zetia and Paroxysmal supraventricular tachycardia - a phase IV clinical study of FDA data

Summary:

Paroxysmal supraventricular tachycardia is reported as a side effect among people who take Zetia (ezetimibe), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have Arrhythmias.

The phase IV clinical study analyzes which people have Paroxysmal supraventricular tachycardia when taking Zetia. It is created by eHealthMe based on reports of 47,765 people who have side effects when taking Zetia from the FDA, and is updated regularly.

What is Zetia?

Zetia has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 49,113 Zetia users. Check the latest studies of Zetia.

What is Paroxysmal supraventricular tachycardia?

Paroxysmal supraventricular tachycardia is found to be associated with 1,092 drugs and 1,872 conditions by eHealthMe. Check the latest studies of Paroxysmal supraventricular tachycardia.

On Apr, 27, 2026

47,765 people reported to have side effects when taking Zetia.
Among them, 69 people (0.14%) have Paroxysmal supraventricular tachycardia.

Could Zetia cause Paroxysmal supraventricular tachycardia?

Among these 69 people:

How long have people been on Zetia when they have Paroxysmal supraventricular tachycardia? *

What is the gender of people who have Paroxysmal supraventricular tachycardia when taking Zetia? *

female: 66.18 %
male: 33.82 %

What is the age of people who have Paroxysmal supraventricular tachycardia when taking Zetia? *

What are other drugs people take besides Zetia? *

What are other side effects people have besides Paroxysmal supraventricular tachycardia? *

Chest Pain: 30 people, 43.48%
Dyspnea (difficult or laboured breathing): 25 people, 36.23%
Nausea (feeling of having an urge to vomit): 20 people, 28.99%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 19 people, 27.54%
Dizziness: 17 people, 24.64%
Pneumonia: 17 people, 24.64%
Fatigue (feeling of tiredness): 16 people, 23.19%
Stress And Anxiety: 16 people, 23.19%
Mitral Valve Incompetence (inefficient heart valve): 16 people, 23.19%
Weakness: 15 people, 21.74%

What are the existing conditions these people have? *

Arrhythmias (irregular heartbeat): 6 people, 8.70%
Multiple Myeloma (cancer of the plasma cells): 5 people, 7.25%
Pancreatic Carcinoma (pancreatic cancer): 4 people, 5.80%
Chest Pain: 3 people, 4.35%
Back Pain: 3 people, 4.35%
Prostatitis (inflammation of the prostate gland): 3 people, 4.35%
Vulvovaginal Dryness: 2 people, 2.90%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 2.90%
Depression: 2 people, 2.90%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 2.90%

* Approximation only. Some reports may have incomplete information.

Do you take Zetia and have Paroxysmal supraventricular tachycardia?

- Check whether Paroxysmal supraventricular tachycardia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zetia:

Zetia (49,113 reports)

Paroxysmal supraventricular tachycardia treatments and more:

Paroxysmal supraventricular tachycardia (17,291 reports)

How severe was Paroxysmal supraventricular tachycardia and when was it recovered:

Paroxysmal supraventricular tachycardia in Zetia

Expand to all the drugs that have ingredients of ezetimibe:

Paroxysmal supraventricular tachycardia and drugs with ingredients of ezetimibe (86 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zetia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Paroxysmal supraventricular tachycardia:

Paroxysmal supraventricular tachycardia (1,092 drugs)

Browse all the conditions that are associated with Paroxysmal supraventricular tachycardia:

Paroxysmal supraventricular tachycardia (1,872 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe (the active ingredients of Zetia) and Zetia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.